Cargando…
Upper airway disease diagnosis as a predictive biomarker of therapeutic response to biologics in severe asthma
Asthma is a heterogeneous disease sharing airway instability but with different biology, risk factors, and response-to-therapy patterns. Biologics have revolutionized the one-size-fits-to-all approach to personalized medicine in severe asthma (SA), which relies on the identification of biomarkers th...
Autores principales: | Cottin, Sophie, Doyen, Virginie, Pilette, Charles |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10073432/ https://www.ncbi.nlm.nih.gov/pubmed/37035303 http://dx.doi.org/10.3389/fmed.2023.1129300 |
Ejemplares similares
-
The Role of IgA in Chronic Upper Airway Disease: Friend or Foe?
por: Sánchez Montalvo, Alba, et al.
Publicado: (2022) -
Biologics and airway remodeling in severe asthma
por: Varricchi, Gilda, et al.
Publicado: (2022) -
COVID-19 and biologics in severe asthma: data from the Belgian Severe Asthma Registry
por: Hanon, Shane, et al.
Publicado: (2020) -
Airway Remodeling in Asthma
por: Hough, Kenneth P., et al.
Publicado: (2020) -
Recent insights in the role of biomarkers in severe asthma management
por: Fouka, Evangelia, et al.
Publicado: (2022)